cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Rapt Therapeutics Inc
9 own
5 watching
Current Price
$9.42
$0.7
(8.03%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
725.91M
52-Week High
52-Week High
31.45000
52-Week Low
52-Week Low
6.86000
Average Volume
Average Volume
1.19M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization725.91M
icon52-Week High31.45000
icon52-Week Low6.86000
iconAverage Volume1.19M
iconDividend Yield--
iconP/E Ratio--
What does the Rapt Therapeutics Inc do?
RAPT Therapeutics, Inc.is a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing oral small molecule therapies for patients with significant unmet needs in oncology and inflammatory diseases.
Read More
How much money does Rapt Therapeutics Inc make?
News & Events about Rapt Therapeutics Inc.
Ticker Report
10 months ago
RAPT Therapeutics, Inc. (NASDAQ:RAPT Get Rating) insider William Ho sold 5,000 shares of the stock in a transaction dated Wednesday, April 19th. The shares were sold at an average price of $18.88, for a total value of $94,400.00. Following the transaction, the insider now directly owns 20,...
PR Newswire
11 months ago
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of RAPT Therapeutics, Inc. - RAPT SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of RAPT Therapeutics, Inc. - RAPT PR Newswire NEW YORK, April 3, 2023 NEW YORK, April 3, 2023...
PR Newswire
11 months ago
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of RAPT Therapeutics, Inc. - RAPT SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of RAPT Therapeutics, Inc. - RAPT PR Newswire NEW YORK, March 22, 2023 NEW YORK, March 22, 2023...
Globe Newswire
11 months ago
ATLANTA, March 20, 2023 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC is investigating whether RAPT Therapeutics, Inc. (RAPT Therapeutics,or the Company) (NASDAQ: RAPT) complied with federal securities laws. On March 14, 2023, the Company disclosed that for its Phase 2b trial of RPT193 in atopic ...
Globe Newswire
11 months ago
Company maintains strong cash position of $249.1 millionSOUTH SAN FRANCISCO, Calif., March 14, 2023 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage, immunology-based therapeutics company focused on discovering, developing and commercializing oral small molecule therapies...
Frequently Asked Questions
Frequently Asked Questions
What is Rapt Therapeutics Inc share price today?
plus_minus_icon
Can Indians buy Rapt Therapeutics Inc shares?
plus_minus_icon
How can I buy Rapt Therapeutics Inc shares from India?
plus_minus_icon
Can Fractional shares of Rapt Therapeutics Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Rapt Therapeutics Inc stocks?
plus_minus_icon
What is today’s traded volume of Rapt Therapeutics Inc?
plus_minus_icon
What is today’s market capitalisation of Rapt Therapeutics Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Rapt Therapeutics Inc?
plus_minus_icon
What percentage is Rapt Therapeutics Inc down from its 52-Week High?
plus_minus_icon
What percentage is Rapt Therapeutics Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$9.42
$0.7
(8.03%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00